Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (12)

2022

  1. Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010

2021

  1. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation

    International Journal of Cardiology, Vol. 345, pp. 29-35

2020

  1. Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14

2019

  1. Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011

  2. Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry

    Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 373-382

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

  2. Multivessel disease in patients over 75 years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI + 75 nation-wide registry

    Cardiovascular Revascularization Medicine, Vol. 19, Núm. 5, pp. 580-588

2017

  1. Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87

  2. Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)

    American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990

2016

  1. Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis

    Circulation: Cardiovascular Interventions, Vol. 9, Núm. 7

2015

  1. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2

    Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 838-845

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386